LCS
XBI icon

Levin Capital Strategies’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Levin Capital Strategies’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-8,377
Closed -$748K – 322
2023
Q4 		$748K Buy
+8,377
New +$622K 0.08% 109
2015
Q4 		– Sell
-9,000
Closed -$560K – 380
2015
Q3 		$560K Sell
9,000
-3,000
-25% -$236K 0.01% 239
2015
Q2 		$1.01M Buy
+12,000
New +$933K 0.01% 206
2014
Q4 		– Sell
-55,191
Closed -$2.87M – 423
2014
Q3 		$2.87M Buy
+55,191
New +$2.81M 0.04% 157

Other funds holding XBI

Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
Citigroup
Citigroup New York $157B AUM 32.99% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $152B AUM 31.61% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $60.6B AUM 31.35% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return